TTRX NASDAQ
Credit Risk of going bust: higher than 58% of companies Debt: 1.9% of company value Bonds: none of note held by US funds details ▾
If the stock fell to about $0.04 (down 99.6%), Turn Therapeutics Inc. would be worth roughly what it owes.
Total debt $6.1M against a stock market value of $322.2M.
Distance to default 4.41 (Merton model): prices to 2026-10-26, balance sheet 2026-06-30, debt counted $3.1M (short-term plus half of long-term), stock volatility 96.9%; Altman Z'' -5.36. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Westlake Village, CA 91362
US
Turn Therapeutics Inc., officially known as Global Health Solutions, Inc., is a pharmaceutical enterprise dedicated to developing treatments for conditions affecting the skin, nails, and eyes. The company utilizes a proprietary drug delivery system engineered to effectively permeate skin and nail tissues. This advanced technology is integrated into their solutions for both acute and chronic wound care, specifically designed to help combat antibiotic resistance. Consequently, these products empower healthcare institutions to effectively manage a broad spectrum of dermatological challenges, encompassing everything from sudden injuries and persistent wounds to general skin ailments and specific dermatoses. Global Health Solutions, Inc. was established in 2015 and maintains its headquarters in Westlake Village, California.
